ACUMEN PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.13 USD | -0.63% |
|
-11.33% | -18.49% |
| Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
| Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Chart calendar Acumen Pharmaceuticals, Inc.
6f203ae3ea007.rAfMbyQIBvKeaaLZ92ZuwvwTS6EZrIT3dBJHviqGxIs.n12YPmVidqrKWpOhryQMuJ1SePIoy8yjGCYN6HDzk83-bL4mfjA0y-RE7w~0c7d7ba35a3b2732b3b4dc99a05a0abe
Upcoming events on Acumen Pharmaceuticals, Inc.
Past events on Acumen Pharmaceuticals, Inc.
| 2024-04-16 08:06 pm | American Academy of Neurology Meeting |
| 2024-04-16 07:30 pm | American Academy of Neurology Meeting |
| 2024-03-26 08:00 am | Q4 2023 Earnings Call |
| 2024-03-26 07:00 am | Q4 2023 Earnings Release |
| 2024-03-19 12:00 pm | Stifel Virtual CNS Conference |
| 2024-01-11 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-14 02:25 pm | Stifel Healthcare Conference |
| 2023-11-13 08:00 am | Q3 2023 Earnings Call |
| 2023-11-13 07:00 am | Q3 2023 Earnings Release |
| 2023-11-09 10:00 am | UBS BioPharma Conference |
| 2023-10-27 09:25 am | Alzheimer Disease Clinical Trials Conference - Diana Kerwin |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Poster #LP 008 |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Poster #P003 |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Poster #LP 034 |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Mirjam Trame |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Eric Siemers |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Poster #LP 033 |
| 2023-10-23 | Alzheimer Disease Clinical Trials Conference - Stephen Salloway |
| 2023-09-26 09:20 am | Cantor Global Healthcare Conference |
| 2023-09-13 10:30 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -19,6 -15,5 -26.32% | -45,2 -40,4 -11.91% | -61,1 -57,0 -7.22% | -75,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -19,6 -16,9 -15.67% | -45,2 -41,3 -9.6% | -61,1 -58,7 -4.07% | -77,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -101 -98,8 -1.83% | -42,9 -41,0 -4.42% | -52,4 -51,2 -2.33% | -77,8 |
|
Net income Million USD | Released Forecast Spread | -7,33 | -101 -97,6 -3.12% | -42,9 -41,0 -4.5% | -52,4 -51,3 -2.15% | -68,6 |
|
EPS USD | Released Forecast Spread | -11,7 | -5,02 -3,46 -44.92% | -1,06 -0,98 -8.67% | -1,08 -1,04 -3.78% | -1,22 |
| Announcement Date | 12/04/21 | 28/03/22 | 27/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -18,5 -18,4 -0.34% | -16,1 | -17,0 | -19,9 | -22,0 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -8,42 -6,57 -28.18% | -9,21 -7,40 -24.41% | -10,4 -10,3 -0.86% | -11,4 -11,2 -1.88% | -14,2 -11,7 -21.45% | -13,1 -14,2 7.65% | -13,5 -14,6 7.92% | -16,0 -14,7 -9.02% | -18,5 -17,3 -7.11% | -16,7 | -17,3 | -19,2 | -20,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,35 -8,30 -0.59% | -10,2 -9,95 -1.99% | -10,7 -11,1 3.32% | -12,9 -12,1 -6.37% | -11,3 -14,5 22.02% | -11,6 -14,5 19.67% | -13,0 -14,5 10.87% | -16,5 -15,3 -7.84% | -10,3 | -11,1 | -12,4 | -13,9 | |
|
Net income Million USD | Released Forecast Spread | -8,35 -8,30 -0.59% | -10,2 -9,81 -3.5% | -10,7 -11,1 3.32% | -12,9 -11,5 -11.61% | -11,3 -14,0 19.4% | -11,6 -14,0 17.1% | -13,0 -14,2 8.69% | -16,5 -15,4 -7.19% | -15,5 | -16,6 | -17,9 | -18,6 | |
|
EPS USD | Released Forecast Spread | 1,98 -0,15 1425.83% | -0,23 -0,17 -35.29% | -0,25 -0,25 -1.35% | -0,26 -0,23 -12.61% | -0,32 -0,25 -28.86% | -0,28 -0,35 18.84% | -0,28 -0,35 19.08% | -0,24 -0,27 9.72% | -0,29 -0,27 -8.35% | -0,27 | -0,29 | -0,32 | -0,34 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 27/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 26/03/24 | - | - | - | - |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| 2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for Acumen Pharmaceuticals, Inc.
| Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABOS Stock
- Calendar Acumen Pharmaceuticals, Inc.
